Assessment of beta-blocker treatment in Japanese patients with chronic heart failure.

Trial Profile

Assessment of beta-blocker treatment in Japanese patients with chronic heart failure.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2013

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Chronic heart failure
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms J-CHF
  • Most Recent Events

    • 27 Aug 2013 Status changed from completed to discontinued.
    • 21 Apr 2012 Results presented at the 18th World Congress of Cardiology.
    • 17 Nov 2009 Results presented as a late-breaking abstract at the 82nd Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top